Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation
Abstract Pemphigus vulgaris (PV) is a rare autoimmune bullous dermatosis (AIBD) characterized by painful blistering of the skin and mucosa caused by autoantibodies that lead to loss of adhesion in the epidermis. Standard therapy for PV is corticosteroids, either alone or in combination with steroid-...
Saved in:
Main Authors: | Nadine Wiedenmayer (Author), Anastasia S. Vollmer (Author), Julia K. Winkler (Author), Alexander H. Enk (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of a Complex Case of Scleromyxedema Using a Novel Intravenous Immunoglobulin Preparation
by: Anastasia Sophie Vollmer, et al.
Published: (2024) -
Successful treatment with thalidomide for pemphigus vulgaris
by: Bingjie Zhang, et al.
Published: (2020) -
Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020) -
Primary laryngeal pemphigus vulgaris with severe epiglottitis
by: Ryoma Honda, et al.
Published: (2022) -
TARC/CCL17 reflects the severity of pemphigus (pemphigus vulgaris and pemphigus foliaceus) at the initial presentation
by: Tomoya Takegami, et al.
Published: (2024)